Kabra Extrusiontechnik Limited Kabra Extrusiontechnik Limited board of directors approved the incorporation of wholly owned subsidiaries in the United Arab Emirates and Vietnam on September 5, 2026. The resolution sanctions an aggregate equity investment of up to ₹750 crore to establish intermediate holding structures and new battery pack manufacturing facilities.

The company aims to expand its international footprint through a two-tier subsidiary structure. The first entity will be incorporated in the UAE as an intermediary holding company for international business operations. This entity requires an aggregate equity investment of up to ₹250 crore.

International Manufacturing Expansion

The second subsidiary will be established in Vietnam, held directly and indirectly through the proposed UAE intermediate holding company. This entity is designated to set up a manufacturing facility specifically for battery packs. The board approved an aggregate investment of up to ₹500 crore for this venture.

The funding for the Vietnam facility is structured to be supported partially by internal accruals and partially by external borrowing. The board also approved the proposal to set up new battery manufacturing plants at suitable locations within India and Vietnam.

What the Numbers Show

The capital allocation reveals a strategic shift toward heavy asset creation in emerging markets. The ₹500 crore commitment for the Vietnam plant represents two-thirds of the total approved outlay, indicating that manufacturing capacity expansion is the primary driver of this international push rather than mere financial holding. The reliance on external borrowing for the Vietnam project suggests the company is leveraging balance sheet strength to accelerate entry into the global battery supply chain, while retaining internal accruals for other operational needs.

Kabra Extrusiontechnik Limited stated it will provide requisite details and make necessary disclosures upon the incorporation of these subsidiaries, in accordance with applicable laws and regulations. The meeting commenced at 11:30 am and concluded at 2:30 pm.

Kabra Extrusiontechnik shareholders approved the company’s ₹141 crore preferential issue of equity shares at an Extraordinary General Meeting (EGM) held on September 2, 2026. The special resolution passed with 99.99% support, as promoters voted unanimously in favour while public dissent remained negligible.

The EGM commenced at 4:00 pm and concluded at 4:40 pm (IST). Mr. Anand Kabra, Chairman and Managing Director, chaired the meeting. The requisite quorum was present, and all existing directors attended. Representatives from the Audit Committee, Risk Management Committee, and other statutory bodies were also present. The Company Secretary, Mr. Hiren Vala, and Chief Financial Officer, Mr. Bhavin Sheth, participated via video conferencing.

Voting Results Breakdown

The combined voting results, disclosed under Regulation 44(3) of the SEBI LODR Regulations, show strong backing from both promoter and public shareholders. A total of 2,15,21,942 votes were polled out of 3,49,72,836 shares held as on the record date of August 25, 2026, representing a participation rate of 61.54%.

Promoters held 2,11,38,635 shares and cast all their votes in favour via remote e-voting. Among public non-institutional shareholders, who held 1,34,51,188 shares, only 3,83,307 votes were polled. Of these, 3,83,067 were in favour and 240 against. No institutional public shareholders participated in the voting.

Regulatory Compliance and Allottee Replacement

The approval follows a recent correction in the allottee list. The Board had previously removed Mr. Saurabh Varma from the proposed allottees on August 28, 2026, after he failed to meet eligibility criteria under Regulation 159(1) of the SEBI ICDR Regulations, 2018. He had sold or transferred shares during the 90 trading days preceding August 3, 2026. Mr. Rakesh Amarlal Hinduja was appointed as his replacement for 26,666 equity shares in the non-promoter category.

Revised Allottee List

The total number of equity shares remains at 37,60,000. The final list of proposed allottees, now approved by shareholders, is detailed below:

Proceeds Utilization Plan

The company intends to utilize the raised funds by June 30, 2027. The allocation focuses on capacity expansion, research and development, and debt reduction. CARE Ratings Limited has been appointed as the Monitoring Agency to ensure compliance with SEBI ICDR Regulations until full utilization.

Actual utilization may deviate by +/- 10% based on market conditions. Any deviation will be used towards stated objects inter-se. Unutilized proceeds may be parked in bank deposits or debt mutual fund schemes.